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Background: Significant direct hyperbilirubinemia, in the absence of biliary tract obstruction, occasionally occurs in patients after implantation of 
axial flow left ventricular assist devices (LVAD). We sought to evaluate the occurrence and prognostic significance of this clinical observation.
Methods: We analyzed post-operative bilirubin levels as well as other laboratory values and their association with all cause mortality in our single 
centre cohort of 127 consecutive patients implanted with the Heartmate II LVAD. Variables are described using median and interquartile range 
(25%;75%).
Results: Patients were 64 (53;70) years old and 44 (35%) were bridged to transplant. Maximal post-operative values were: bilirubin total 3.8 mg/
dl (2.1;7.8), direct 1.45 mg/dl(0.5;4.6), Alkaline Phosphatase 150 (102;230), ALT u/L69.5 (41;127.5), AST u/L 136 (75;230) and LDH 582 mg/
dl (472-847). Total bilirubin values >5 mg/dl were observed in 46 (37%) patients and values >20 in 10 (8%). Over one (0.6;1.6) year of follow 
up 13 patients died within 90 days of implant. Peak levels of bilirubin were associated with increased 90-day mortality (Total bilirubin Chi2=31.3, 
p<0.0001, Direct bilirubin Chi2=28.5, p<0.0001). Higher bilirubin within 3 days of operation was also significantly associated with 90-day mortality 
both for total (Chi2=12.6, p=0.0004) and direct (Chi2=15.1, p=0.0001) values.
Conclusions: We describe for the first time the significant occurrence of hyperbilirubinemia after LVAD implantation. Early hyperbilirubinemia after 
LVAD may predict poor outcome. The etiology of this important observation is yet to be explored but may be multi-factorial in origin. 
